Back to Search
HEATHER CARRICOFFE MCCARTHY DO
DO
Family Medicine Physician
NPI: 1972625218Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS 9885(FL)
Research & Publications (20)
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.
PMID 19062185·J Gene Med·2009
7-preclinical
RANK, RANKL and osteoprotegerin in bone biology and disease.
PMID 19468919·Curr Rev Musculoskelet Med·2009
8-other
Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells.
PMID 18814141·J Cell Physiol·2009
7-preclinical
The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
PMID 18256696·Gene Ther·2008
7-preclinical
Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.
PMID 18644193·J Pharm Pharmacol·2008
6-review
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
PMID 18669603·Endocrinology·2008
8-other
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy.
PMID 18556084·J Control Release·2008
7-preclinical
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?
PMID 18615772·J Gene Med·2008
7-preclinical
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.
PMID 18512241·Int J Cancer·2008
7-preclinical
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
PMID 17257990·Ann Thorac Surg·2007
3-trial
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
PMID 17471586·J Gene Med·2007
8-other
p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.
PMID 17006546·Gene Ther·2007
7-preclinical
A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--'keep your waist circumference to less than half your height'.
PMID 16432546·Int J Obes (Lond)·2006
8-other
Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure.
PMID 16458228·J Cardiothorac Vasc Anesth·2006
8-other
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
PMID 16515902·J Thorac Cardiovasc Surg·2006
4-observational
Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.
PMID 16410820·Cancer Gene Ther·2006
7-preclinical
Body fat measurements in children as predictors for the metabolic syndrome: focus on waist circumference.
PMID 17181905·Proc Nutr Soc·2006
6-review
Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
PMID 16731183·Ann Thorac Surg·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3301 COLLEGE AVE
DAVIE, FL 33314 - Phone
- (954) 262-5590
Quick Facts
- NPI
- 1972625218
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile